SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-139787
Filing Date
2017-04-26
Accepted
2017-04-26 17:26:59
Documents
10
Period of Report
2017-06-08
Effectiveness Date
2017-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d331579ddef14a.htm DEF 14A 634377
2 GRAPHIC g3315791.jpg GRAPHIC 2383
3 GRAPHIC g33157913.jpg GRAPHIC 977
4 GRAPHIC g331579132.jpg GRAPHIC 1232
5 GRAPHIC g3315792.jpg GRAPHIC 3315
6 GRAPHIC g3315793.jpg GRAPHIC 1096
7 GRAPHIC g331579g08s42.jpg GRAPHIC 26785
8 GRAPHIC g331579g17v31.jpg GRAPHIC 817
9 GRAPHIC g331579g54f03.jpg GRAPHIC 37893
10 GRAPHIC g331579g72b42.jpg GRAPHIC 28256
  Complete submission text file 0001193125-17-139787.txt   777828
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30929 | Film No.: 17785487
SIC: 2834 Pharmaceutical Preparations